Table 2.
First maintenance treatment with budesonide.
| Median (range) or n (%) | ||||
|---|---|---|---|---|
| First maintenance | All patients (n=56) | Lymphocytic colitis (n=19) | Collagenous colitis (n=37) | |
| Bowel movements, number | 5 (3–15) | 5 (3–15) | 6 (3–15) | |
| Smoking history | 39 (69.6%) | 10 (52.6%) | 29 (78.4%) | |
| Maintenance duration, days | 302 (56–2,258) | 113 (56–1,387) | 379 (84–2,258) | |
| Maintenance initial dose | 6 mg daily | 43 (76.8%) | 12 (63.2%) | 31 (83.8%) |
| 3 mg daily | 13 (23.2%) | 7 (36.8%) | 6 (16.2%) | |
| Maintenance lowest dose | 6 mg daily | 10 (17.9%) | 5 (26.3%) | 5 (13.5%) |
| 3 mg daily | 40 (71.4%) | 13 (68.4%) | 27 (72.9%) | |
| 3 mg every other day | 6 (10.7%) | 1 (5.3%) | 5 (13.5%) | |
| Maintenance outcome | Complete | 55 (98.2%) | 19 (100%) | 36 (97.3%) |
| Partial | 1 (1.8%) | 0 (0%) | 1 (2.7%) | |
| No response | 0 (0%) | 0 (0%) | 0 (0%) | |
| Intolerance | 0 (0%) | 0 (0%) | 0 (0%) | |
| Recurrence | 26 (46.4%) | 4 (21.1%) | 22 (59.5%) | |